BRCA2 is a human tumor suppressor gene, found in all humans; its protein, called by the synonym breast cancer type 2 susceptibility protein, is responsible for repairing DNA.
| FactSnippet No. 733,821 |
BRCA2 is a human tumor suppressor gene, found in all humans; its protein, called by the synonym breast cancer type 2 susceptibility protein, is responsible for repairing DNA.
| FactSnippet No. 733,821 |
BRCA1 and BRCA2 have been described as "breast cancer susceptibility genes" and "breast cancer susceptibility proteins".
| FactSnippet No. 733,822 |
BRCA2 gene is located on the long arm of chromosome 13 at position 12.
| FactSnippet No. 733,823 |
BRCA2 mutations are usually insertions or deletions of a small number of DNA base pairs in the gene.
| FactSnippet No. 733,824 |
Researchers believe that the defective BRCA2 protein is unable to fix DNA damage that occurs throughout the genome.
| FactSnippet No. 733,825 |
Women having inherited a defective BRCA1 or BRCA2 gene have risks for breast and ovarian cancer that are so high and seem so selective that many mutation carriers choose to have prophylactic surgery.
| FactSnippet No. 733,826 |
Major determinants of where BRCA1- and BRCA2-associated hereditary cancers occur are related to tissue specificity of the cancer pathogen, the agent that causes chronic inflammation, or the carcinogen.
| FactSnippet No. 733,827 |
Methods to diagnose the likelihood of a patient with mutations in BRCA1 and BRCA2 getting cancer were covered by patents owned or controlled by Myriad Genetics.
| FactSnippet No. 733,828 |
All germline BRCA2 mutations identified to date have been inherited, suggesting the possibility of a large "founder" effect in which a certain mutation is common to a well-defined population group and can theoretically be traced back to a common ancestor.
| FactSnippet No. 733,829 |
AtBRCA2 protein is required for proper localization of the synaptonemal complex protein AtZYP1 and the recombinases AtRAD51 and AtDMC1.
| FactSnippet No. 733,830 |
BRCA2 is required in the mouse for neurogenesis and suppression of medulloblastoma.
| FactSnippet No. 733,831 |
Epigenetic alterations in expression of BRCA2 are very frequent in sporadic cancers while mutations in BRCA2 are rarely found.
| FactSnippet No. 733,832 |
In non-small cell lung cancer, BRCA2 is epigenetically repressed by hypermethylation of the promoter.
| FactSnippet No. 733,833 |
In eukaryotes, BRCA2 protein has an important role in homologous recombinational repair.
| FactSnippet No. 733,834 |
BRCA2 contains a number of 39 amino acid repeats that are critical for binding to RAD51 and resistance to methyl methanesulphonate treatment.
| FactSnippet No. 733,835 |
The Tower domain has an important role in the tumour suppressor function of BRCA2, and is essential for appropriate binding of BRCA2 to DNA.
| FactSnippet No. 733,836 |